Microbiota Analysis to Predict Outcomes of Rheumatoid Arthritis Patients Treated With JAK-inhibitor | MicrobiomeTrials← Back to trialsNCT04530305
Microbiota Analysis to Predict Outcomes of Rheumatoid Arthritis Patients Treated With JAK-inhibitor
SUSPENDEDOBSERVATIONAL
Trial Details
Start: 2021-01-07Est. Completion: 2026-09-16
Enrollment target: 60 participants Locations- CHU de Montpellier, Montpellier, France
Other microbiome trials you might be interested in
Autoimmune Diseases
Background:
Autoimmune diseases can be caused by genes people inherit from their parents. The gene changes that cause t…
Bethesda, United StatesEst. completion Apr 22, 2030
Rheumatic DiseasesLupus Erythematosus, SystemicLupus Vasculitis, Central Nervous SystemArthritisSpondylarthritisAnkylosing SpondylarthritisRheumatoid ArthritisSjogren's Syndrome
Background:
Rheumatic diseases can affect the joints, ligaments, tendons, bones, muscles, and skin. They can also cause…
Bethesda, United StatesEst. completion Jun 15, 2033